Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2023

Aug 14, 2023

32227_dirs_2023-08-14_051f3205-b83b-4bbf-889c-2b520108f186.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2023-08-10

Reporting Person: Gunn Neil (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-08-10 Stock Option (Right to Buy) $14.82 A 8353 Acquired 2033-08-10 Common Stock (8353) Direct
2023-08-10 Restricted Stock Unit $0 A 11336 Acquired Common Stock (11336) Direct

Footnotes

F1: Once vested, the shares of common stock are not subject to expiration.